Topics

Companies Related to "The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma" [Most Relevant Company Matches] RSS

01:43 EST 27th January 2020 | BioPortfolio

Here are the most relevant search results for "The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma" found in our extensive corporate database of over 50,000 company records.

Showing "Effect Allergen Immunotherapy Anti viral Immunity Patients With" Companies 1–25 of 4,900+

Relevant

Allergen Research Corporation

Allergen Research Corporation (ARC), founded in 2011, is developing treatments to protect children with food allergies from the life-threatening consequences of accidental exposure. ARC’s work, which builds on more than a decade of groundbreaking research in oral immunotherapy by the company’s academic and nonprofit collaborators, aims to establi...


Gibson Oncology, LLC

Gibson is a private oncology drug development company dedicated to bringing its novel, cost-effective, and very well-tolerated Indeno anti-cancer treatments to market. Gibson intends to develop these novel anti-cancer drugs in advanced-stage cancer patients as single agent and in combination treatments with both immunotherapy and targeted therapies.

Serametrix Corporation

Serametrix provides solutions to the problem of monitoring immune response to immunotherapies in clinical trial cancer patients. In partnership with leading institutes Serametrix has developed a suite of immunoassays that monitor anti-tumor immunity in patients enrolled into clinical trials for novel cancer therapies. Serametrix is part owned by the LICR. ...


BioMedica Inc.

Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange.Oxford BioMedica’s products use genes as the mediators of a therapeutic effect and/or immune response...

Allergy Immuno Technologies Incorporated

Allergy Immuno Technologies, Inc. (AIT) and its predecessors commenced development activities in allergy and immune disorder research diagnostic reagents and services in 1980. AIT currently operates a clinical reference laboratory at 1527 Monrovia Avenue, Newport Beach, CA, for allergy and other diagnostic testing services for physicians, other laboratories and pharmaceutical companies. As a resul...

Marinomed Biotechnologie GmbH

Marinomed is a biopharmaceutical company discovering and developing innovative anti-viral and immunological treatments. Marinomed develops therapies against respiratory diseases based on its innovative anti-viral respiratory technology platform mavirex. Safety and efficacy of the mavirex technology have already been proven in clinical trials. The huge potential of the technology is reflected by...

OxyPharma AB

OxyPharma's lead compound B-220 has its origin in anti-viral research conducted by Professor Jan Bergman between 1971 and 1975. In the following years and financed by Kabi – a Swedish pharmaceutical company Professor Bergman synthesized the substance. Its anti-viral properties were confirmed in collaboration with the Bacteriological Laboratory of Sweden (SBL). Professor Bergman continued his res...

Viral Genetics

Viral Genetics is developing immune-based therapies for the treatment of HIV/AIDS and other infectious, autoimmune, and immunological deficiency disorders. The Company’s primary product candidate is VGV-1, an investigational therapy for the treatment of HIV/AIDS that has demonstrated an antiviral effect in clinical trials with an apparent immunological mechanism of action. VGV-1 is a suspension ...

Advaxis, Inc. 

Advaxis, Inc. is a late-stage biotechnology company focused on the discovery, development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-based stra...

AlloVir

AlloVir (formerly ViraCyte), founded in 2013 by researchers at Baylor College of Medicine’s Center for Cell and Gene Therapy, is the leader in the development of novel cell therapies with a focus on restoring natural T-cell immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s...

World of Health Biotech Co.Ltd

Anti HBV Specific Active Immunotherapy (Anti HBV Therapeutic Vaccine) using recombinant hepatitis B vaccine (standard HBV vaccine) as an immunogenic specific antigen and several cytokines as an immune adjuvant is a new antiviral approach for chronic HBV infection. The first and most critical setp in the design of an anti HBV therapeutic vaccine is the selection of the specific antigens that will b...

Stallergenes Greer plc

Allergies are the most prevalent and fastest growing chronic diseases in the industrialized world, affecting over one billion people worldwide. Allergen immunotherapy uniquely alters the natural course of respiratory allergies. It is the only therapeutic class capable of modifying disease progression and potentially preventing the onset of the disease by inducing tolerance in the immune system.

International Therapeutics Incorporated

International Therapeutics, Inc. (ITI) is developing a novel anti-viral technology called Nuclear Importation Inhibition (NII) that may be applied against chronic viral disease such as HIV-1, hepatitis B (HBV), and herpes viruses. The technology is the subject of eight issued US patents and a series of foreign filings.The Company, started in 1999, has set up offices and laboratories in Seattle to ...

Biothera Pharmaceuticals Inc.

Biothera Pharmaceuticals is a privately held biotechnology company developing Imprime PGG, a first-in-class, mid-clinical stage cancer immunotherapy that orchestrates an integrated anti-cancer immune response in combination with checkpoint inhibitors and tumor-targeting and anti-angiogenesis monoclonal antibodies. Imprime PGG has been well-tolerated in tri...

Aimmune Therapeutics, Inc.

Aimmune Therapeutics, Inc., founded in 2011 as Allergen Research Corporation (ARC), is a clinical-stage biopharmaceutical company developing treatments for peanut and other food allergies. Aimmune Therapeutics’ characterized oral desensitization immunotherapy (CODIT™) system, an approach to oral immunotherapy (OIT), combines proprietary product c...

Spring Bank Technologies Inc

Spring Bank Technologies (SBT) (the Company) is a biotechnology company located in Milford,Massachusetts. Founded in 2002, the Company is engaged in the discovery and development ofnovel anti-viral therapies against human viral diseases. The Company’s proprietary technologyplatform is built around nucleic acid-based chemistries for the discovery of novel small moleculecompounds that work by sele...

Surface Oncology, Inc.

Surface is creating the next generation of immunotherapies for cancer. To fully unlock the potential of cancer immunotherapy, Surface is targeting a broader set of immune processes by which cancer cells evade immune recognition and attack. Our programs are built upon emerging, proprietary insights about how to improve the immune system’s recognition a...

APOTEX PHARMACHEM

Founded in 1974 as a distributor of pharmaceutical ingredients, it was in the late 1980's with the advent of research and manufacturing of active pharmaceutical ingredients ("APIs"), that Apotex Pharmachem Inc. ("API") began its impressive growth. API is a proud member of the Apotex Group of companies, Canada's largest manufacturer and provider of high quality generic pharmaceuticals to the Canadi...

Genetic Immunity, LLC

Genetic Immunity is a biopharmaceutical company focused on therapeutic vaccine development and commercialization. The lead product, DermaVir vaccine patch, is under clinical evaluation in Hungary and in the USA for the treatment for HIV/AIDS, where resistance, toxicity, adherence and cost limit the use of drugs. The Company’s vaccine composition mimics the successful induction of antiviral immun...

Trimeris, Inc.

Trimeris, Inc. (Nasdaq: TRMS) is a biopharmaceutical company engaged in the commercialization of therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. FUZEON®, approved in the U.S., Canada and European Union, is the first in a new class of anti-HIV drugs ...

Imposter Research

IMPOSTER is the name of a medical research study of patients with muscle symptoms while taking cholesterol lowering therapies called statins. Several important findings from this study have been published and have raised questions about the safety of statin therapy for patients with muscle complaints. This website was developed to address those questions and to share what is known about statin mu...

Asthma, Allergy & Immunology Clinic

Allergic rhinitis or "hay fever." Symptoms of allergic rhinitis are sneezing, congestion, itching and dripping of the nose, and itchy, watery eyes. There are basically two types of allergic rhinitis: seasonal (for example, during fall, spring, or both) and perennial (year-round). Seasonal allergic rhinitis refers to allergies caused by pollen from trees, grasses, and/or weeds. Perennial allergic r...

CARMA Therapeutics Inc.

CARMA TherapeuticsSM is a biotechnology company founded in 2016 to bring the power of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA). The company’s proprietary technology was developed at the Center for Cellular Immunotherapy at the Perelman School of Medicine at the...

United Allergy Services

United Allergy Services™ (UAS) brings effective and convenient allergy testing and immunotherapy to primary care physicians; pulmonologists; ENT physicians; pediatricians; internal medicine physicians; and healthcare systems that treat the vast majority of patients with seasonal and perennial allergies. UAS’ complete service line features ...

Eminent effect

The eminent effect is a consultancy aiming to stand out from the crowd in tackling many of today’s people and business challenges. The company offers organisation specific training, development, sales/marketing and interim management solutions not off the shelf packages.Primarily working within the NHS, Pharmaceutical and Biotechnology sectors, the eminent effect personnel can offer experience g...


More From BioPortfolio on "The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma"

Quick Search

Corporate Database Quicklinks